Follow along: 1. The WavSTAT4 mentioned at the

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Follow along:


1.
The WavSTAT4 mentioned at the Medical Technologies Advisory Committee:

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
Medical Technologies Advisory Committee (MTAC)
Minutes of the 49th meeting on 19 March 2015

https://www.google.com/url?sa=t&rct=j&...3917,d.dmo
Scroll down to Page 4 of 5..

Quote:
10. MT264 The WavSTAT 4 optical biopsy system for the real time histological assessment of colon polyps in vivo
Prof Venkataraman Subramanian declared a non-personal interest for this technology. Dr James East declared a personal pecuniary and non-personal interest for this technology.
The Committee was asked if there were any specific equality issues to consider in relation to this technology.
Introduced by Brian Selman, Venkataraman Subramanian and James East.
The Committee then considered the technology for selection and routing


2.
The Medical Technologies Advisory Committee operates as a standing advisory committee of the Board of NICE .

This committee (MTAC) advised NICE on:
•Which new medical devices and diagnostics to evaluate
•Deciding which programme within NICE will evaluate each of the new medical devices and diagnostics.


3.
In the UK, The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care.

Read more about NICE
https://www.nice.org.uk/Media/Default/About/W...harter.pdf

4.
It's great to see the wavSTAT4 being mentioned at such high level meetings; especially when these meetings are designed to improve the health and social care of the UK.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 4

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading

Top 5 Most Recently Viewed Articles

CoreWeave Gains Amid NVIDIA Partnership, Faces Skepticism

Updated Category News Views 205

CoreWeave Stock Surges with NVIDIA Agreement Shares of CoreWeave, Inc. experienced a notable increase recently following the announcement of a significant partnership with NVIDIA Corp. This new agreement, valued at an initial $6.3 billion, allows NVIDIA to purchase any excess cloud computing capacity that CoreWeave may have available. The partnership is expected to last...

Continue Reading
Coty's Preliminary Q1 Review: Sales Growth Insights and Strategy

Updated Category News Views 65

Coty Inc. Preliminary Q1 Overview Coty Inc. (NYSE: COTY) has recently reported its preliminary numbers for the first quarter, revealing some intriguing insights into its sales growth. The company experienced a modest increase of approximately 4%-5% on a like-for-like basis, which unfortunately fell short of their previous estimate of 6%. This slight underperformance has...

Continue Reading
Uncle Funky's Daughter Launches Innovative Hair Mousse

Updated Category News Views 420

Introducing Soul Bounce Texture Defining Mousse Uncle Funky's Daughter, a celebrated minority-owned hair care brand, has introduced an innovative product known as Soul Bounce Texture Defining Mousse. This exciting addition aims to elevate the hairstyling routine for individuals with textured hair, offering a solution that balances definition, volume, and health. The...

Continue Reading
Arconic Corporation Faces Class Action Lawsuit Over Securities Losses

Updated Category News Views 205

Arconic Corporation's Legal Challenges for Investors In the ever-evolving landscape of corporate governance, Arconic Corporation is currently facing serious legal scrutiny. Investors are being made aware that a class action lawsuit has been initiated against the company, highlighting concerns over significant losses among shareholders. Class Action Overview This lawsuit...

Continue Reading
Key Insights on Centene Corporation Class Action for Investors

Updated Category News Views 131

Understanding the Centene Corporation Class Action Lawsuit In recent developments, Centene Corporation (NYSE: CNC) has found itself at the center of a class action lawsuit. This legal proceeding has garnered attention due to allegations that Centene and its senior executives may have violated federal securities laws. Legal representation is being offered by a leading firm...

Continue Reading